Categories

Blood donation was promoted by health authorities at Dominican Republic

[Original text in Spanish]

Santo Domingo, República Dominicana – En el marco del Día Mundial del Donante de Sangre, el Ministerio de SaludPública (MSP) junto al Gabinete de Coordinación de Políticas Sociales de la Vicepresidencia de la República Dominicana y la Organización Panamericana de la Salud/Organización Mundial de Salud (OPS/OMS)realizaron un acto conmemorativo en el que las autoridades se reunieron para agradecer a los donantes voluntarios no remunerados y concientizar de la necesidad de hacer donaciones voluntarias regulares para garantizar la calidad, seguridad y disponibilidad de sangre y sus productos.

El Día Mundial del Donante de Sangre, que se celebra el 14 de junio, tiene este año como tema “Date a los demás. Dona sangre. Comparte vida”. El objetivo es poner de relieve el papel que tienen los sistemas de donación voluntaria de sangre al alentar a las personas a cuidarse unas a otras.

Source: http://msp.gob.do/Autoridades-promueven-la-donacion-de-sangre-en-la-Republica-Dominicana

 
Categories

INVIMA launches new bulletin with recommendations for safe consumption, “We take care of your health”.

In order to provide advice on self-care and safe consumption to Colombians, the National Institute for Surveillance of Drugs and Food (Invima) launches its new bulletin “Cuidamos tu Salud”.

This publication has 5 sections, designed to offer recommendations for safe consumption and alert citizens about inappropriate practices and habits of the products they use and consume on a daily basis that may affect their health.

Check the bulletin here

Source: https://www.invima.gov.co/%C2%B4cuidamos-tu-salud%C2%B4-nuevo-bolet%C3%ADn-con-recomendaciones-de-consumo-seguro.html

 
Categories

World Blood Donor Day 2018

Be there for someone else. Give blood. Share life. 14 June 2018 Every year, on 14 June, countries around the world celebrate World Blood Donor Day. The event serves to thank voluntary, unpaid blood donors for their life-saving gifts of blood and to raise awareness of the need for regular blood donations to ensure the quality, safety and availability of blood and blood products for patients in need.

Transfusion of blood and blood products helps save millions of lives every year. It can help patients suffering from life-threatening conditions live longer and with a higher quality of life, and supports complex medical and surgical procedures. It also has an essential, life-saving role in maternal and child care and during the emergency response to man-made and natural disasters.

A blood service that gives patients access to safe blood and blood products in sufficient quantity is a key component of an effective health system. An adequate supply can only be ensured through regular donations by voluntary, unpaid blood donors. However, in many countries, blood services face the challenge of making sufficient blood available, while also ensuring its quality and safety.

For more information go to https://www.paho.org/hq/index.php?option=com_content&view=article&id=14307&Itemid=72270&lang=en

 
Categories

FDA – Deeper Dive Webinar: Postmarketing Drug Safety and Inspection Readiness – June 19, 2018

The Food and Drug Administration, Center for Drug Evaluation and Research and Small Business and Industry Assistance (CDER SBIA), welcomes you to our webinar series.

Tuesday, June 19, 2018
10:00am – 2:00pm (Eastern)

For more information go to https://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm608748.htm 

 
Categories

FDA approves first biosimilar to Neulasta to help reduce the risk of infection during cancer treatment

June 4, 2018

The U.S. Food and Drug Administration today approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta (pegfilgrastim) to decrease the chance of infection as suggested by febrile neutropenia (fever, often with other signs of infection, associated with an abnormally low number of infection-fighting white blood cells), in patients with non-myeloid (non-bone marrow) cancer who are receiving myelosuppressive chemotherapy that has a clinically significant incidence of febrile neutropenia.

(…)

For more information go to https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm609805.htm

 
Categories

CECMED as ICH observer

[Original text in Spanish]

CECMED participated for the second time in its capacity as Observer in the Assembly of the current International Council for the Harmonization of Technical Requirements for Pharmaceutical Products for Human Use (ICH), held this time in Montreal, Canada, from May 31 to 1. June. There he shared with the membership, representatives of the industry, international organizations, working groups and with the other eight Medicines Regulatory Authorities that make up ICH, following the established program.

For more information go to http://www.cecmed.cu/content/cecmed-observador-ich

 
Categories

Anvisa receives EU Audit for Pharmaceutical Supplies

[Original text in Portuguese]

Inspections will be carried out from June 12 to 21 with the objective of reassessing the maintenance of Brazil’s status with the White List criterion.

A team of European Union (EU) auditors was at Anvisa in Brasilia on Tuesday, June 12 to begin the process of assessing the maintenance of country status included in the list of countries with equivalence in the controls of pharmaceutical supplies, called the White List.

For more information go to  http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/4530380